Molecular and Cellular Biology, October 1998, p. 5818-5827, Vol. 18, No. 10
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Eukaryotic Transcription Laboratory,
Received 17 December 1997/Returned for modification 5 February
1998/Accepted 28 July 1998
Perhaps the best characterized example of an activator-induced
chromatin transition is found in the activation of the
Saccharomyces cerevisiae acid phosphatase gene
PHO5 by the basic helix-loop-helix (bHLH) transcription
factor Pho4. Transcription activation of the PHO5 promoter
by Pho4 is accompanied by the remodeling of four positioned nucleosomes
which is dependent on the Pho4 activation domain but independent of
transcription initiation. Whether the requirements for transcription
activation through the TATA sequence are different from those necessary
for the chromatin transition remains a major outstanding question. In
an attempt to understand better the ability of Pho4 to activate
transcription and to remodel chromatin, we have initiated a detailed
characterization of the Pho4 activation domain. Using both deletion and
point mutational analysis, we have defined residues between positions
75 and 99 as being both essential and sufficient to mediate
transcription activation. Significantly, there is a marked concordance
between the ability of mutations in the Pho4 activation domain to
induce chromatin opening and transcription activation. Interestingly, the requirements for transcription activation within the Pho4 activation domain differ significantly if fused to a heterologous bHLH-leucine zipper DNA-binding domain. The implications for
transcription activation by Pho4 are discussed.
*
Corresponding author. Mailing address: Eukaryotic
Transcription Laboratory, Marie Curie Research Institute, The Chart,
Oxted, Surrey RH8 0TL, United Kingdom. Phone: 44 1883 722306. Fax: 44 1883 730426. E-mail: c.goding{at}mcri.ac.uk.
Present address: Department of Pathology, Washington University
School of Medicine, St. Louis, MO 63110-1093.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|